U.S. Pharma Stock News

The recent price decline of 10.0% in Synergy CHC Corp.'s ( NASDAQ:SNYR ) stock may have disappointed insiders who...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...

Healthpeak Properties (NYSE:DOC) has arranged a new $400 million unsecured delayed draw term loan facility. The facility is available on a delayed draw basis, giving the company added flexibility on when to access the capital. This move is designed to strengthen liquidity and support future capital allocation decisions. For REIT investors watching balance sheet strength, this new facility marks a meaningful update for Healthpeak Properties at a time when the shares trade around $17.17. The...

Investors may be considering whether Peoples Bancorp at around US$32 is offering value right now, or if most of the upside has already been taken. The stock has returned 0.6% over the last 7 days and declined 6.0% over 30 days. It is up 6.1% year to date, 11.5% over 1 year, 43.4% over 3 years and 27.5% over 5 years. Recent coverage has focused on Peoples Bancorp as part of broader regional bank discussions and longer term share price performance context. For investors, this backdrop helps...

AAON, a US-based HVAC manufacturer backed by two million square feet of lab testing space, has in recent years seen day-to-day expenses rise faster than revenue, driving a 3.7 percentage point reduction in operating margin and a very large annual decline in earnings per share even as sales increased. This tension between growing revenue and shrinking profitability raises fresh questions about how effectively AAON is controlling costs and converting its growing order book into sustainable...

WeRide (NasdaqGM:WRD) has capped FY 2025 with fourth quarter revenue of C¥314 million and a basic EPS loss of C¥1.71, while trailing twelve month figures show revenue of C¥684.6 million and a net income loss of C¥1.65 billion. Over recent quarters, the company has seen revenue move from C¥70.0 million and a basic EPS loss of C¥14.79 in Q3 2024 to C¥140.8 million with a C¥2.43 loss per share in Q4 2024, then to C¥72.4 million and a C¥1.27 loss in Q1 2025 before reaching C¥314 million in Q4...

A bipartisan group of US senators has introduced a bill to restrict prediction markets from offering sports betting style contracts and casino type products. The proposal targets platforms such as Kalshi and Polymarket, which currently sit outside the traditional US sports betting regulatory framework. If enacted, the bill would tighten the rules around unregulated competitors to licensed sportsbooks, including Flutter Entertainment's US operations. Flutter Entertainment (NYSE:FLUT),...

If you are wondering whether First Industrial Realty Trust at around US$58.06 is offering fair value or not, this article walks through what the current data suggests about the price you see on screen. The stock has recently been mixed, with a 4.8% decline over the last 7 days and a 6.5% decline over 30 days, even though returns stand at 0.3% year to date and 10.7% over 1 year, 24.3% over 3 years, and 42.2% over 5 years. Recent news flow around First Industrial Realty Trust has focused on...

If you are wondering whether United States Antimony at US$8.94 still offers value after a big run, this breakdown is designed to help you frame that question clearly. The stock shows a 300.9% return over the last year and a very large 3 year gain of 2,267.6%. At the same time, the 7 day return of an 18.6% decline and the 30 day return of 21.0% highlight recent volatility on top of a 50.8% year to date move. This price action has drawn more attention to United States Antimony, with investors...

Caledonia Mining (NYSEAM:CMCL) has put up a busy FY 2025 so far, with Q3 revenue of US$68.0 million and basic EPS of US$0.77, sitting within a trailing 12 month backdrop where earnings grew by a very large 917.5% and the net profit margin reached 21.9% versus 3% a year earlier. Over recent quarters the company has seen revenue move from US$45.1 million in Q4 2024 to US$53.4 million in Q1 2025, US$61.8 million in Q2 2025 and US$68.0 million in Q3 2025. Quarterly basic EPS shifted from US$0.25...

Arbutus Biopharma FY 2025 Earnings Snapshot Arbutus Biopharma (ABUS) has turned in a mixed FY 2025 readout so far, with Q3 total revenue at US$0.5 million and a basic EPS loss of US$0.04, alongside trailing twelve month revenue of US$14.6 million and a basic EPS loss of US$0.22. Over recent quarters, the company has reported revenue in a range between US$0.5 million and US$10.7 million per quarter, while quarterly basic EPS has ranged from a loss of US$0.13 to a profit of US$0.01. This gives...

Jabil (NYSE:JBL) has committed $1.1 million over multiple years to support advanced manufacturing training at St. Petersburg College. The partnership will fund scholarships, upgrade manufacturing curriculum, and expand access to advanced technology for students in the Tampa Bay region. This initiative is aimed at developing a stronger local manufacturing talent pipeline and deepening Jabil's community engagement. For investors tracking NYSE:JBL, this move comes with the stock at a share...

If you are wondering whether Patria Investments is starting to look like value at around US$11.51, the next step is to see how that price compares with what the business might be worth. The stock has had a mixed run, with a 1.1% gain over the last 7 days, a 17.8% decline over the past 30 days, and a 27.7% decline year to date, while the 1 year return sits at 2.0% and the 3 and 5 year returns are 5.7% and 11.3% declines respectively. Those swings have put valuation firmly in focus for many...

Bally's (BALY) FY 2025 earnings snapshot Bally's (BALY) latest FY 2025 update centers on Q3 numbers, with revenue of US$663.7 million, a basic EPS loss of US$1.70, and net income loss of US$102.9 million as the company continues to operate in the red. Over recent quarters, revenue has ranged from US$580.4 million in Q4 2024 to US$663.7 million in Q3 2025, while quarterly basic EPS has moved between a loss of US$0.30 and a loss of US$5.10, underscoring pressure on profitability. For investors,...

Idaho Strategic Resources (IDR) has put up another solid set of numbers for FY 2025 so far, with third quarter revenue at about US$11.1 million, basic EPS of US$0.20 and trailing 12 month EPS of US$0.73 underpinning net income of US$10.27 million over the past year. The company has seen revenue step up from US$6.2 million in Q2 FY 2024 to US$7.6 million in Q4 FY 2024 and then to US$11.1 million in Q3 FY 2025. Quarterly basic EPS moved from US$0.17 to US$0.18 and now just over US$0.20, setting...

Teekay Corporation Ltd. has reported past full-year 2025 results, with sales of US$949.52 million and net income of US$98.11 million, both lower than the prior year. The decline in basic earnings per share from continuing operations, from US$1.47 to US$1.14, underscores pressure on Teekay’s underlying profitability. With earnings showing reduced revenue and profit, we’ll examine how this softer performance shapes Teekay’s investment narrative going forward. The latest GPUs need a type of...

Recent performance snapshot and why AvalonBay Communities is on investors’ radar AvalonBay Communities (AVB) has drawn fresh attention after a stretch of weaker share performance, with a 1 day return of -2.34% adding to negative moves over the past week and month. Over the past year, the stock shows a total return of -22.01%, while year to date it is down 10.59%. For readers tracking multi year trends, the 3 year and 5 year total returns stand at 13.11% and 1.92% respectively. See our latest...

Recent price performance and context Armstrong World Industries (AWI) has seen its share price under pressure recently, with an approximate 18% decline over the past month and 14% over the past 3 months, drawing investor attention to its fundamentals. See our latest analysis for Armstrong World Industries. The recent 18% 1 month share price decline and 14% 3 month share price decline sit against a different longer run picture, with a 1 year total shareholder return of 13.03% and 3 year total...

AEye (LIDR) has just joined the NVIDIA Halos AI Systems Inspection Lab while also releasing fourth quarter and full year 2025 results, a combination that puts both its technology partnerships and financial profile in focus. See our latest analysis for AEye. The share price has been volatile around these announcements, with a 7 day share price return of 44.52% and a 1 day decline of 13.51%. Over 1 year, the total shareholder return is very large compared to the longer term 3 year and 5 year...

Wondering if MDU Resources Group at around US$19.65 is offering value right now, or if the recent run puts it on the expensive side. The stock has pulled back about 4.7% over the past week and 2.9% over the past month, although the 1 year return sits at 18.7% and the 3 and 5 year returns are 91.5% and 89.5% respectively. Recent coverage has focused on MDU Resources Group as a regulated utility and infrastructure business. Investors are paying attention to how its mix of operations and...

EMCOR Group (NYSE:EME) has been added to the FTSE All-World Index. This index inclusion is effective with the latest rebalance of FTSE Russell global benchmarks. The move may draw additional attention from institutional and index tracking investors. For EMCOR Group, trading at $724.93, inclusion in a global benchmark index comes after a very large 5 year return and a 76.0% return over the past year. Even with a 10.8% decline over the past 30 days and a 0.2% decline over the past week, the...

Investors may be wondering if Astera Labs at around US$116 per share still offers value after a big run, or if they might be late to the story. The stock is up 63.2% over the last year, although the 7 day, 30 day and year to date returns of 3.5%, 10.5% and 35.4% declines show that enthusiasm has cooled recently. Recent coverage has focused on Astera Labs as a key player in semiconductor infrastructure and AI related hardware. This helps explain why the share price has attracted attention...

SS Innovations International, Inc. reported past 2025 results showing full-year revenue rising to US$42.48 million from US$20.65 million, while narrowing its net loss to US$12.13 million and disclosing auditor concerns about its ability to continue as a going concern. Separately, the company’s SSi Mantra surgical robotic system secured approval for telesurgeries in Indonesia and the Philippines and passed 150 cumulative telesurgeries, signaling expanding real-world use of its technology...

Recent stock performance and what it might signal Tyra Biosciences (TYRA) has drawn attention after a 2.7% decline in the last session, following a sharp move over the past 3 months that left the stock up 46.4%. Over the past month the shares are up 17.6%, while the 1 year total return stands at 247.5%, set against a recent closing price of US$37.15 and a market value of about US$2.0b. See our latest analysis for Tyra Biosciences. Put simply, Tyra Biosciences has combined sharp short term...